SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Multiple Presentations at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
July 22, 2021 20:14 ET | Sight Sciences, Inc.
MENLO PARK, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world's most...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 19, 2021 17:22 ET | Sight Sciences, Inc.
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Pricing of Initial Public Offering
July 14, 2021 18:53 ET | Sight Sciences, Inc.
MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devises that target...